A.L.S. Drug Relyvrio Fails Clinical Trial and May Be Withdrawn From the Market


Pam Belluck
3/8/2024

Leaders of the treatment’s manufacturer, Amylyx, said they would announce their plans for it within eight weeks....

Original

Tags: drug | leaders | market | plans | trial



Let us know what you think!

Click on a star to rate it!

Average rating 0 / 5. Vote count: 0

No votes so far! Be the first to rate this post.

Leave a Comment

Scroll back to top